Literature DB >> 31300923

Correction to: Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer.

Edoardo Isnaldi1, Domenico Ferraioli1,2, Lorenzo Ferrando1, Sylvain Brohée3, Fabio Ferrando1,4, Piero Fregatti1,4, Davide Bedognetti5, Alberto Ballestrero1,4, Gabriele Zoppoli6,7.   

Abstract

In the original publication of the article, the funding information was incorrectly published. The corrected funding statement is given in this correction article.

Entities:  

Year:  2019        PMID： 31300923     DOI： 10.1007/s10549-019-05348-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


  2 in total

1.  SLFN11 captures cancer-immunity interactions associated with platinum sensitivity in high-grade serous ovarian cancer.

Authors:  Claudia Winkler; Matthew King; Julie Berthe; Domenico Ferraioli; Anna Garuti; Federica Grillo; Jaime Rodriguez-Canales; Lorenzo Ferrando; Nicolas Chopin; Isabelle Ray-Coquard; Oona Delpuech; Darawan Rinchai; Davide Bedognetti; Alberto Ballestrero; Elisabetta Leo; Gabriele Zoppoli
Journal:  JCI Insight       Date:  2021-09-22

Review 2.  A wake-up call for cancer DNA damage: the role of Schlafen 11 (SLFN11) across multiple cancers.

Authors:  Bingnan Zhang; Kavya Ramkumar; Robert John Cardnell; Carl Michael Gay; C Allison Stewart; Wei-Lien Wang; Junya Fujimoto; Ignacio I Wistuba; Lauren Averett Byers
Journal:  Br J Cancer       Date:  2021-07-22       Impact factor: 9.075
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.